Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Operating Income Loss of $1.10 billion for the year ending 2025.
- ZIMMER BIOMET HOLDINGS, INC. showed a decrease of -14.6% in Operating Income Loss from 2024 to 2025.
- This data is from ZIMMER BIOMET HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), ZIMMER BIOMET HOLDINGS, INC.'s Operating Income Loss has grown by 0.7%.
- Historical annual values: Fiscal year 2025: $1.10 billion | Fiscal year 2024: $1.29 billion | Fiscal year 2023: $1.28 billion | Fiscal year 2022: $696.30 million | Fiscal year 2021: $860.30 million | Fiscal year 2020: $83.10 million | Fiscal year 2019: $1.14 billion | Fiscal year 2018: $33.80 million | Fiscal year 2017: $799.30 million | Fiscal year 2016: $821.10 million | Fiscal year 2015: $467.30 million | Fiscal year 2014: $1.04 billion | Fiscal year 2013: $1.07 billion | Fiscal year 2012: $1.05 billion | Fiscal year 2011: $1.02 billion | Fiscal year 2010: $916.70 million | Fiscal year 2009: $1.02 billion | Fiscal year 2008: $1.09 billion.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: